BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 26313918)

  • 1. The novel protective role of P27 in MLN4924-treated gastric cancer cells.
    Zhang Q; Hou D; Luo Z; Chen P; Lv B; Wu L; Ma Y; Chu Y; Liu H; Liu F; Yu S; Zhang J; Yang D; Liu J
    Cell Death Dis; 2015 Aug; 6(8):e1867. PubMed ID: 26313918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRFAP1 plays a protective role in neddylation inhibitor MLN4924-mediated gastric cancer cell death.
    Hu L; Bai ZG; Ma XM; Bai N; Zhang ZT
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8273-8280. PubMed ID: 30556867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
    Lan H; Tang Z; Jin H; Sun Y
    Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14-3-3ζ targeting induced senescence in Hep-2 laryngeal cancer cell through deneddylation of Cullin1 in the Skp1-Cullin-F-box protein complex.
    Seo SB; Baek JY; Lim JH; Jin X; Lee MY; Lee JH
    Cell Prolif; 2019 Sep; 52(5):e12654. PubMed ID: 31222857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization of Human Colorectal Cancer Cells by MLN4924: An Inhibitor of NEDD8-Activating Enzyme.
    Wan J; Zhu J; Li G; Zhang Z
    Technol Cancer Res Treat; 2016 Aug; 15(4):527-34. PubMed ID: 26082455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells.
    Mackintosh C; García-Domínguez DJ; Ordóñez JL; Ginel-Picardo A; Smith PG; Sacristán MP; de Álava E
    Oncogene; 2013 Mar; 32(11):1441-51. PubMed ID: 22641220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death.
    Li Z; Wang JW; Wang WZ; Zhi XF; Zhang Q; Li BW; Wang LJ; Xie KL; Tao JQ; Tang J; Wei S; Zhu Y; Xu H; Zhang DC; Yang L; Xu ZK
    Free Radic Biol Med; 2016 Oct; 99():593-607. PubMed ID: 27634171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.
    Chen P; Hu T; Liang Y; Jiang Y; Pan Y; Li C; Zhang P; Wei D; Li P; Jeong LS; Chu Y; Qi H; Yang M; Hoffman RM; Dong Z; Jia L
    Oncotarget; 2015 Apr; 6(11):9002-17. PubMed ID: 25797246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing VDAC1 expression induces a non-apoptotic role for pro-apoptotic proteins in cancer cell differentiation.
    Arif T; Krelin Y; Shoshan-Barmatz V
    Biochim Biophys Acta; 2016 Aug; 1857(8):1228-1242. PubMed ID: 27080741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
    Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
    Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
    Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
    Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIS targeting induces cellular senescence through the regulation of 14-3-3 zeta/STAT3/SKP2/p27 in glioblastoma cells.
    Lee JJ; Lee JS; Cui MN; Yun HH; Kim HY; Lee SH; Lee JH
    Cell Death Dis; 2014 Nov; 5(11):e1537. PubMed ID: 25412315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer.
    Pan WW; Zhou JJ; Yu C; Xu Y; Guo LJ; Zhang HY; Zhou D; Song FZ; Fan HY
    J Biol Chem; 2013 Oct; 288(41):29680-91. PubMed ID: 23995842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MLN4924 suppresses neddylation and induces cell cycle arrest, senescence, and apoptosis in human osteosarcoma.
    Zhang Y; Shi CC; Zhang HP; Li GQ; Li SS
    Oncotarget; 2016 Jul; 7(29):45263-45274. PubMed ID: 27223074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth.
    Luo Z; Yu G; Lee HW; Li L; Wang L; Yang D; Pan Y; Ding C; Qian J; Wu L; Chu Y; Yi J; Wang X; Sun Y; Jeong LS; Liu J; Jia L
    Cancer Res; 2012 Jul; 72(13):3360-71. PubMed ID: 22562464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial ROS accumulation inhibiting JAK2/STAT3 pathway is a critical modulator of CYT997-induced autophagy and apoptosis in gastric cancer.
    Cao Y; Wang J; Tian H; Fu GH
    J Exp Clin Cancer Res; 2020 Jun; 39(1):119. PubMed ID: 32576206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
    Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
    Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoobtusilactone A induces cell cycle arrest and apoptosis through reactive oxygen species/apoptosis signal-regulating kinase 1 signaling pathway in human breast cancer cells.
    Kuo PL; Chen CY; Hsu YL
    Cancer Res; 2007 Aug; 67(15):7406-20. PubMed ID: 17671211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.
    Jung D; Khurana A; Roy D; Kalogera E; Bakkum-Gamez J; Chien J; Shridhar V
    Sci Rep; 2018 Feb; 8(1):2487. PubMed ID: 29410485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
    Xu B; Deng Y; Bi R; Guo H; Shu C; Shah NK; Chang J; Liu G; Du Y; Wei W; Wang C
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1083-1093. PubMed ID: 29667067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.